Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- B6619 RR-srcSummary: Tyrosine kinase substrate peptide
- B6693 Lavendustin ASummary: EGFR tyrosine kinase inhibitor
- B6746 SU 4312Summary: VEGFR and PDGFR tyrosine kinases inhibitor
- B6808 Herbimycin ASummary: antibiotic,Src family kinase inhibitor
- B6828 K 252aSummary: protein kinase inhibitor
- B6869 Demethylasterriquinone B1Summary: insulin receptor (IR) activator
- B6891 DamnacanthalSummary: p56lck tyrosine kinase inhibitor
- B7190 PP 3Summary: Negative control for the Src kinase inhibitor PP 2
- B7407 Insulin (human) recombinant expressed in yeastTarget: Insulin ReceptorsSummary: Endogenous insulin receptor agonist
- B7764 HNGF6ASummary: increases glucose stimulated insulin secretion and glucose metabolism